loader2
Partner With Us NRI

Company details

0.00
0.00
0.00
0.00
6M Return -
1Y Return -
Mkt Cap.(Cr) -
Volume -
Div Yield -
OI
-
OI Chg %
-
Volume -

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

No Data Found
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
-
5.9%
0
0%
0%
Description
  • Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segment includes pharmaceutical formulations in the form of tablets, capsules, liquid orals, oral powder, dry syrups, ointments, insta use suspension, form fill and seal (FFS), liquid injectables and dry powder injectables. Its clients include Ranbaxy Laboratories Limited, Cipla Limited, Sandoz Private Limited, Abbott India Limited, USV Limited, Plizer Limited and Sanofi Aventis.The company is a public limited company listed at Bombay Stock Exchange and National Stock Exchange of India Limited. The company was incorporated in the year 1995. Ankur has to its credit several distinctions. It`s in the forefront of contract manufacturing with India`s leading and multinational pharmaceutical companies. Ankur`s first plant is situated at Daman, which is having dedicated block for General and Betalactum products in oral dosage form. The Company has set-up two plants spread across `dimensions` at Himachal Pradesh in excise and pollution free zone, amongst lush green surroundings. The main object behind setting up two units was to cater Domestic and International Market. The company`s 400 different formulations of various dosage forms i.e. Tablets, Capsules, Dry Syrups, Liquid Orals, Injectables, Oinments, etc. are currently manufactured in Ankur`s multi location manufacturing facilities. Company has already received WHO GMP Certification for both Units at Himachal Pradesh. As of March 31, 2010, it had installed capacities of 15,720 million tablets, 2,886 million capsules and 300 million effervescent tablets. During the fiscal year ended March 31, 2010 (fiscal 2010), it had a production of 9,800 million tablets, 2,090 million capsules and 157 million effervescent tablets. During fiscal 2010, it had in-house developed mosquito repellant patch from ayurvedic formulations.

Read More

Registered Address

C-306 Crystal Plaza, Andheri Link Road Andheri(W), Mumbai, Maharashtra, 400053

Tel : 91-22-40682300
Email : srane:ankurdrugs.com
Website : http://www.ankurdrugs.com

Registrar

Ajel Infotech Ltd

AGM Date (Month) : Dec
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531683
NSE Code : ANKURDRUGS
Book Closure Date (Month) : Dec
BSE Group :
ISIN : INE238D01012

ICICIdirect Ankur Drugs & Pharma Ltd FAQ

You can buy Ankur Drugs & Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ankur Drugs & Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of the closing price of Ankur Drugs & Pharma Ltd was ₹ -.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of , the market cap of Ankur Drugs & Pharma Ltd stood at ₹ 0.00.
The latest PE ratio of Ankur Drugs & Pharma Ltd as of is 0
The latest PB ratio of Ankur Drugs & Pharma Ltd as of is 0
The 52-week high of Ankur Drugs & Pharma Ltd is ₹ 0 while the 52-week low is ₹ 0 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE